Cognition Therapeutics Inc [NASDAQ: CGTX] loss -29.03% on the last trading session, reaching $1.54 price per share at the time.
Cognition Therapeutics Inc represents 88.22 million in outstanding shares, while the company has a total market value of $113.14 million with the latest information. CGTX stock price has been found in the range of $1.44 to $2.26.
If compared to the average trading volume of 11.03M shares, CGTX reached a trading volume of 13859169 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Cognition Therapeutics Inc [CGTX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CGTX shares is $3.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CGTX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
B. Riley Securities have made an estimate for Cognition Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 19, 2024. The new note on the price target was released on July 30, 2024, representing the official price target for Cognition Therapeutics Inc stock. Previously, the target price had yet another raise to $22, while Oppenheimer analysts kept a Outperform rating on CGTX stock.
The Price to Book ratio for the last quarter was 14.23, with the Price to Cash per share for the same quarter was set at 0.16.
Trading performance analysis for CGTX stock
Cognition Therapeutics Inc [CGTX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -35.83. With this latest performance, CGTX shares dropped by -7.23% in over the last four-week period, additionally plugging by 244.21% over the last 6 months – not to mention a rise of 119.59% in the past year of trading.
Cognition Therapeutics Inc (CGTX) Capital Structure & Debt Analysis
According to recent financial data for Cognition Therapeutics Inc. ( CGTX), the Return on Equity (ROE) stands at -219.68%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -122.22%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Cognition Therapeutics Inc’s Return on Invested Capital (ROIC) is -454.57%, showcasing its effectiveness in deploying capital for earnings.
Cognition Therapeutics Inc (CGTX) Efficiency & Liquidity Metrics
Based on Cognition Therapeutics Inc’s (CGTX) latest financial statements, the Debt-to-Equity Ratio is 0.07%, indicating its reliance on debt financing relative to shareholder equity.
Cognition Therapeutics Inc (CGTX) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Cognition Therapeutics Inc. (CGTX) effectively leverages its workforce, generating an average of -$1178214.29 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.54% and a Quick Ratio of 1.54%, indicating strong ability to cover short-term liabilities.
Cognition Therapeutics Inc [CGTX]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Cognition Therapeutics Inc posted -0.25/share EPS, while the average EPS was predicted by analysts to be reported at -0.21/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.04. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CGTX.
An analysis of Institutional ownership at Cognition Therapeutics Inc [CGTX]
There are presently around $12.74%, or 12.83%% of CGTX stock, in the hands of institutional investors. The top three institutional holders of CGTX stocks are: VANGUARD GROUP INC with ownership of 1.15 million shares, which is approximately 2.8644%. AWM INVESTMENT COMPANY, INC., holding 0.65 million shares of the stock with an approximate value of $$1.08 million in CGTX stocks shares; and AWM INVESTMENT COMPANY, INC., currently with $$0.83 million in CGTX stock with ownership which is approximately 1.248%.
